Candriam Luxembourg S.C.A. »

Definium Therape shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-03-31 $24M 1.3M 18.90

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Alphabet Cap Stk Cl C (GOOG)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
McKesson Corporation (MCK)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape